Introduction
Apotex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights
Apotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. The company also offers biosimilars, active pharmaceutical ingredients and pharmaceuticals. It carries out the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and development (R&D) facilities in Montreal, Richmond Hill, Brantford, Windsor, Winnipeg, Toronto, Etobicoke, Mississauga, London, Calgary and Vancouver. It serves patients, healthcare providers and payers, governments and other pharmaceutical manufacturers. It operates through subsidiaries, joint ventures and licensing agreements across Americas, Europe, the Middle East, Africa and Asia-Pacific. Apotex is headquartered in Toronto, Ontario, Canada.
Apotex Inc Key Recent Developments
Dec 19,2018: Apotex names Jeff Watson as leader after CEO Jack Kay departs
Aug 10,2018: FDA approves first generic drug under new CGT designation
Aug 08,2018: CannTrust and Apotex accelerate partnership to fuel global expansion in medical cannabis market
May 09,2018: Apotex Announces Proposed Merger of AUS & NZ Operations
Mar 08,2018: Advisory - Chipped pills in additional packages of Alysena 21 and 28 birth control pills
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
for Apotex Inc - Strategic SWOT Analysis Review [Report Updated: 31-01-2019]
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Apotex Inc - Key Facts 5
Apotex Inc - Key Employees 6
Apotex Inc - Key Employee Biographies 7
Apotex Inc - Major Products and Services 8
Apotex Inc - History 10
Apotex Inc - Company Statement 12
Apotex Inc - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 15
Company Overview 15
Apotex Inc - Business Description 16
Apotex Inc - SWOT Analysis 17
SWOT Analysis - Overview 17
Apotex Inc - Strengths 17
Apotex Inc - Weaknesses 18
Apotex Inc - Opportunities 19
Apotex Inc - Threats 20
Apotex Inc - Key Competitors 21
Section 3 – Company’s Lifesciences Financial Deals and Alliances 22
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 23
Apotex Inc, Recent Deals Summary 24
Section 4 – Company’s Recent Developments 25
Aug 10, 2018: FDA approves first generic drug under new CGT designation 25
Aug 08, 2018: CannTrust and Apotex accelerate partnership to fuel global expansion in medical cannabis market 26
May 09, 2018: Apotex Announces Proposed Merger of AUS & NZ Operations 27
Mar 08, 2018: Advisory - Chipped pills in additional packages of Alysena 21 and 28 birth control pills 28
Section 5 – Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29
List Of Tables
in Apotex Inc - Strategic SWOT Analysis Review [Report Updated: 31-01-2019]
List of Tables
Apotex Inc, Key Facts 5
Apotex Inc, Key Employees 6
Apotex Inc, Key Employee Biographies 7
Apotex Inc, Major Products and Services 8
Apotex Inc, History 10
Apotex Inc, Subsidiaries 13
Apotex Inc, Key Competitors 21
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 23
Apotex Inc, Recent Deals Summary 24
List Of Figures, Charts and Diagrams
in Apotex Inc - Strategic SWOT Analysis Review [Report Updated: 31-01-2019]
List of Figures
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22
Apotex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 23
Additional Details
Publisher
Global Data
Publisher Information
Reference
230729 | GDPH6309SA
Number of Pages
29
Report Format

Related Reports
Title | Date Published | Price from | More Details |
---|---|---|---|
Apotex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile SummaryApotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. It also und... | 13 Nov 2018 by Global Data | USD $250 | More Info |
Apotex, Inc. - Strategy, SWOT and Corporate Finance Report SummaryApotex, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive comp... | 28 Dec 2016 by Marketline | USD $175 | More Info |
Apotex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile SummaryApotex Inc (Apotex) is a pharmaceutical company that carries out the production and marketing... | 22 Nov 2016 by Global Data | USD $250 | More Info |
Apotex Partnering Deals and Alliances 2010 to 2016 The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering... | 01 Nov 2016 by Current Partnering | USD $1,495 | More Info |
Apotex, Inc. - Strategy, SWOT and Corporate Finance Report SummaryApotex, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive comp... | 21 Oct 2016 by Marketline | USD $175 | More Info |
Apotex Partnering Deals and Alliances 2010 to 2016 The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering... | 01 Oct 2016 by Current Partnering | USD $1,495 | More Info |
Apotex Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile SummaryApotex Inc. (Apotex) is a pharmaceutical company that carries out the production and marketin... | 29 Jul 2016 by Global Data | USD $250 | More Info |
Apotex, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report SummaryMarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments r... | 15 Apr 2016 by Marketline | USD $350 | More Info |
Apotex Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile SummaryApotex Inc. (Apotex) is a pharmaceutical company that carries out the production and marketin... | 05 Apr 2016 by Global Data | USD $250 | More Info |
Apotex Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile SummaryApotex Inc. (Apotex) is a pharmaceutical company that carries out the production and marketin... | 03 Mar 2016 by Global Data | USD $250 | More Info |
This report is published by Global Data
Download Free Report Summary PDF
![Apotex Inc - Strategic SWOT Analysis Review [Report Updated: 31-01-2019] | Download PDF Summary Apotex Inc - Strategic SWOT Analysis Review [Report Updated: 31-01-2019] | Download PDF Summary](img/xpdf-summary.jpg.pagespeed.ic.PvEUQqtmCi.jpg)
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Ordering Information
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Accepted Card Types

Buy now using our secure payment system.